Plasma glutathione peroxidase in pediatric stroke families

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 1, 2011, Pages 33-38

  Nowak Gottl U ^a   Fiedler, B ^b   Huge, A ^c   Niederstadt, T ^b   Thedieck, S ^a   Seehafer, T ^c   Stoll, M ^c  

^a Department of Pediatric Hematology/Oncology ^*  (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cerebral sinovenous thrombosis; GPX3; Pediatric stroke

Indexed keywords

GLUTATHIONE PEROXIDASE;

ADOLESCENT; ADULT; ALLELE; ARTERIOPATHY STROKE; ARTICLE; BOOTSTRAPPING; BRAIN ISCHEMIA; CEREBRAL SINUS THROMBOSIS; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NUCLEAR FAMILY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOEMBOLIC STROKE; THROMBOEMBOLISM;

ADOLESCENT; ADULT; CEREBRAL ANGIOGRAPHY; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERMANY; GLUTATHIONE PEROXIDASE; HAPLOTYPES; HEREDITY; HUMANS; INFANT; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ODDS RATIO; PEDIGREE; PHENOTYPE; PHLEBOGRAPHY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; STROKE; THROMBOEMBOLISM; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 78650946163     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04103.x     Document Type: Article

References (33)

1. Earley CJ, Kittner SJ, Feeser BR, Gardner J, Epstein A, Wozniak MA, Wityk R, Stern BJ, Price TR, Macko RF, Johnson C, Sloan MA, Buchholz D. Stroke in children and sickle-cell disease: Baltimore-Washington-Cooperative Young Stroke Study. Neurology 1998; 51: 169-76.
2. Kirkham FJ, Prengler M, Hewes DK, Ganesan V. Risk factors for arterial ischemic stroke in children. J Child Neurol 2000; 15: 299-307.
3. Haywood S, Liesner R, Pindora S, Ganesan V. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child 2005; 90: 402-5.
4. DeVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald EA, Gillett J, Meaney B, Shevell M, Sinclair DB, Yager J, Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-23.
5. Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knöfler R, Schobess R, Zieger B, Sébire G, Nowak-Göttl U, European Thromboses Study Group. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol 2007; 6: 595-603.
6. Kenet G, Lütkhoff LK, Albisetti M, Bernard TJ, Bonduel M, Brandao LR, Chabrier S, Chan A, Fiedler B, Fullerton HJ, Ganesan V, Goldenberg NA, Golomb M, Grabowski EF, Heller C, Holzhauer S, Iorio A, Journeycake J, Kirkham FJ, Kurnik K, et al. Impact of thrombophilia on arterial ischemic stroke or cerebral venous sinus thromboses in children: a systematic review & meta-analysis of observational studies. Circulation 2010; 121: 1838-47.
7. Mills GC. Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. J Biol Chem 1957; 229: 189-97.
8. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 1990; 8: 583-95.
9. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN. Characterization of mammalian selenoproteomes. Science 2003; 300: 1439-43.
10. Bierl C, Voetsch B, Jin RC, Handy DE, Loscalzo J. Determinants of human plasma glutathione peroxidase (GPx-3) expression. J Biol Chem 2004; 279: 26839-45.
11. Yoshimura S, Suemizu H, Taniguchi Y, Arimori K, Kawabe N, Moriuchi T. The human plasma glutathione peroxidase-encoding gene: organization, sequence and localization to chromosome 5q32. Gene 1994; 145: 293-7.
12. Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest 1996; 97: 979-87.
13. Kenet G, Freedman J, Shenkman B, Regina E, Brok-Simoni F, Holzman F, Vavva F, Brand N, Michelson A, Trolliet M, Loscalzo J, Inbal A. Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children. Arterioscler Thromb Vasc Biol 1999; 19: 2017-23.
14. Voetsch B, Jin RC, Bierl C, Benke KS, Kenet G, Simioni P, Ottaviano F, Damasceno BP, Annichino-Bizacchi JM, Handy DE, Loscalzo J. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene. A novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007; 38: 41-9.
15. Voetsch B, Jin RC, Bierl C, Deus-Silva L, Camargo ECS, Annichino-Bizacchi JM, Handy DE, Loscalzo J. Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke 2008; 39: 303-7.
16. Grond-Ginsbach C, Lichy C, Padovanti A, Pezzini A. GPx-3 gene promoter variation and the risk of arterial ischemic stroke. Stroke 2007; 38: e23.
17. Grond-Ginsbach C, Arnold ML, Lichy C, Grau A, Renner K. No association of the plasma glutathione peroxidase (GPx-3) gene with cerebral venous thrombosis in the German population. Stroke 2009; 40: e34.
18. Bernard TJ, Goldenberg NA, Tripputi M, Manco-Johnson MJ, Niederstadt T, Nowak-Göttl U. Anticoagulation in childhood-onset arterial ischemic stroke with nonmoyamoya arteriopathy. Stroke 2009; 40: 2869-71.
19. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology 1997; 49: 1541-5.
20. Kirkham F, Sebire G, Steinlin M, Sträter R. Arterial ischaemic stroke in children. Review of the literature and strategies for future stroke studies. Thromb Haemost 2004; 92: 697-706.
21. Zhang W, Collins A, Morton NE. Does haplotype diversity predict power for association mapping of disease susceptibility? Hum Genet 2004; 115: 157-64.
22. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-16.
23. deBakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-23.
24. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
25. Goldstein DB. Islands of linkage disequilibrium. Nat Genet 2001; 29: 109-11.
26. Johnson GCL, Esposito L, Barrett BJ, Amith AN, Heward J, DiGenova DG, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-7.
27. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88: 756-62.
28. Bockenstedt P. Laboratory methods in hemostasis. In: Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage, 2nd edn. Baltimore: Williams & Wilkins, 1998: 405-18.
29. Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, Stone WH, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000; 101: 1546-51.
30. Nowak-Göttl U, Langer C, Bergs S, Thedieck S, Sträter R, Stoll M. Genetics of hemostasis. Differential effects of heritability and household components influencing lipid concentrations and clotting factor levels in 282 pediatric stroke families. Environ Health Perspect 2008; 116: 839-43.
31. Avissar N, Ornt DB, Yagil A, Horowitz S, Watkins RH, Kerl EA, Takahashi K, Palmer IS, Cohen HJ. Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol 1994; 266: C367-75.
32. Yoshimura S, Suemizu H, Nomoto H, Sakai H, Katasuoka Y, Kawamura N, Moriuchi T. Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron 1996; 73: 207-11.
33. El-Far MA, Bakr MA, Farahat SE, Abd El-Fattah EA. Glutathione peroxidase activity in patients with renal disorders. Clin Exp Nephrol 2005; 9: 127-31.